Tag: insulin

Not all drugs used to treat type 2 diabetes are equal in terms of long-term survival, according to a new observational study (Schramm TK et al. Eur Heart J. doi: 10.1093/eurheartj/ehr077 [published ahead of print April 6, 2011]). The study included all Danish residents older than 20 years who had begun taking either single-agent insulin secretagogues ...

Adocia, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced positive results from its phase I clinical study evaluating the safety and clinical utility of HinsBet(R), its fast-acting human insulin product for the treatment of diabetes. The trial compared the product candidate, HinsBet(R), to NovoLog(R) (Novo Nordisk), a fast-acting ...

A new study shows that an alternate form of insulin may be approved in upcoming years that is longer lasting, overall helping patients living with diabetes to have an improved quality of life by not having to inject themselves daily. This incidence may be able to be cut in half. People diagnosed with type 1 diabetes ...

ScienceDaily (Dec. 28, 2010) — New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called "starvation hormone" affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival. The results connect multiple observations about how the hormone adiponectin functions and eventually could lead to new treatments for conditions ...

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 60 percent of surveyed type 2 diabetes patients in the U.S. who currently use insulin indicate they would request that their doctor switch them to a less expensive biosimilar insulin if such an agent became available.

Small details between "in vivo" and "in vitro" studies make for big differences in understanding diabetes and other secretory dysfunctions Exocytosis, the fundamental process by which cells secrete hormones such as insulin and other useful biological substances, is regulated far differently in life than in laboratory tissue cultures and explanted organs, according to researc...

ScienceDaily (Dec. 13, 2010) — Men with type 1 diabetes may be able to grow their own insulin-producing cells from their testicular tissue, say Georgetown University Medical Center (GUMC) researchers who presented their findings Dec. 12 at the American Society of Cell Biology 50th annual meeting in Philadelphia. Their laboratory and animal study is a proof ...

WASHINGTON (Reuters) - Stem cells can be transformed into the pancreatic cells needed to treat diabetes and into complex layers of intestinal tissue, scientists demonstrated in two experiments reported on Sunday. In one, a team turned immature sperm cells into pancreatic tissue, while another team turned embryonic stem cells into complex layers of intestinal tissue. Both studies ...

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major global pharmaceutical company to test Access' oral insulin formulation based upon its proprietary vitamin B-12-based CobOral™ Drug Delivery ...

A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.